Early research (Phase 1)Study completedNCT07340216
What this trial is testing
Maximal Usage Pharmacokinetics and Safety Study of ARQ-154 Foam 0.3% in Pediatric Participants With Scalp and Body Psoriasis
Who this might be right for
Psoriasis
Arcutis Biotherapeutics, Inc. 22